Genomics provides an overview of the complete set of genetic instructions provided by the DNA, while proteomics studies dynamic protein products and their interactions. Genetics and genomics both play roles in health and disease. Gen Consulting Company predicts genomics and proteomics tools market in China will grow from USD 2,344 million in 2021 to USD 4,597 million by 2028, achieving a CAGR of 10.1 percent, according to the latest edition of the Genomics and Proteomics Tools Market in China Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into genomics and proteomics tools market in China. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the genomics and proteomics tools industry.

This industry report offers market estimates and forecasts of the China market, followed by a detailed analysis of the product, and technology. The China market for genomics and proteomics tools can be segmented by product: instruments, reagents and consumables, software. The reagents and consumables segment was the largest contributor to the China genomics and proteomics tools market in 2021. Genomics and proteomics tools market is further segmented by technology: PCR, flow cytometry, mass spectrometry, NGS sequencing, nucleic acid purification, nucleic acid separation, others.

By product:
– instruments
– reagents and consumables
– software

By technology:
– PCR
– flow cytometry
– mass spectrometry
– NGS sequencing
– nucleic acid purification
– nucleic acid separation
– others

The report also provides analysis of the key companies of the industry and their detailed company profiles including Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Hitachi High-Tech Corporation, Illumina, Inc., Merck KGaA, Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the genomics and proteomics tools market in China.
– To classify and forecast the genomics and proteomics tools market in China based on product, technology.
– To identify drivers and challenges for the genomics and proteomics tools market in China.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the genomics and proteomics tools market in China.
– To identify and analyze the profile of leading players operating in the genomics and proteomics tools market in China.

Why Choose This Report
– Gain a reliable outlook of the genomics and proteomics tools market in China forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.